Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia

J Pediatr Hematol Oncol. 2004 Mar;26(3):197-9. doi: 10.1097/00043426-200403000-00011.

Abstract

Acute febrile neutrophilic dermatosis (Sweet syndrome) has been reported in a few adults receiving all-trans retinoic acid for acute promyelocytic leukemia. The authors report a case of Sweet syndrome associated with the administration of all-trans retinoic acid for acute promyelocytic leukemia in a pediatric patient.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Child
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Skin / pathology
  • Sweet Syndrome / chemically induced*
  • Sweet Syndrome / pathology
  • Treatment Outcome
  • Tretinoin / adverse effects*

Substances

  • Antineoplastic Agents
  • Tretinoin